Instil Bio, Inc.
TIL · XNASCIK 1789769fmd_0MHCC6EABRMXX63E2JRXJ1XCYQManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2020 to Jun 30, 2026, 26 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | – | – | – | – |
| Rental revenue | – | – | – | 0 | 4 | 9 |
| Research and development | 19 | 107 | 141 | 40 | 12 | 25 |
| Total operating expenses | 34 | 156 | 226 | 159 | 74 | 79 |
| Operating income | (34) | (156) | (226) | (159) | (74) | (79) |
| Interest expense | – | 0 | 2 | 5 | 9 | 6 |
| Other non-operating income (expense) | (4) | (1) | (1) | (1) | (3) | 0 |
| Income before taxes | (38) | (157) | (225) | (156) | (74) | (71) |
| Income tax expense | 0 | 0 | (2) | 0 | – | 0 |
| Net income from continuing operations | (38) | (157) | (223) | (156) | – | (71) |
| Net income | (38) | (157) | (223) | (156) | (74) | (71) |